Сравнение

Cetrorelix vs. Enfuvirtid

Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.

Идентичность

Категория

Исследования (прочее)

Номер CAS

120287-85-6

159519-65-0

Молекулярная масса

1431.06 g/mol

4491.88 g/mol

Период полувыведения

нет данных

Последовательность

нет данных

Механизм действия

Cetrorelix

Cetrorelix competitively and immediately blocks the pituitary GnRH receptor, rapidly suppressing LH and FSH release — without the initial hormone surge ('flare') of GnRH agonists.

Enfuvirtid

Enfuvirtide binds the first heptad-repeat region (HR1) of the gp41 subunit of the HIV envelope protein. This prevents the conformational change required for fusion of the viral and cell membranes — the virus cannot enter the cell.

Доказательная база

Наивысшая доказательность

РКИ на людях

Исследования

из них на людях

Зафиксированные эффекты

Открытые противоречия

Задокументированные нежелательные явления

Правовой статус

Country	Cetrorelix	Enfuvirtid
Германия	Рецептурный	Рецептурный
США	Рецептурный	Рецептурный

Полные записи

Frequently asked questions

What is the difference between Cetrorelix and Enfuvirtid?: Cetrorelix is classified as "Исследования (прочее)", while Enfuvirtid is classified as "Исследования (прочее)". Cetrorelix: Cetrorelix is a synthetic decapeptide and GnRH antagonist. It is used in assisted reproduction (IVF) to prevent a premature LH surge during controlled ovarian stimulation. Enfuvirtid: Enfuvirtide is a synthetic 36-amino-acid peptide and the first HIV-1 fusion inhibitor. It binds the HR1 region of the viral envelope protein gp41, blocking viral entry into the cell. Approved for treatment-experienced HIV patients. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Cetrorelix or Enfuvirtid?: The highest available evidence level is "РКИ на людях" for Cetrorelix and "РКИ на людях" for Enfuvirtid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Cetrorelix and Enfuvirtid in Germany and the United States?: Германия: Cetrorelix — Рецептурный, Enfuvirtid — Рецептурный. США: Cetrorelix — Рецептурный, Enfuvirtid — Рецептурный. These are factual summaries with source and review date on the individual pages.

Country

Cetrorelix

Enfuvirtid

Германия

Рецептурный

США

Рецептурный

Frequently asked questions

What is the difference between Cetrorelix and Enfuvirtid?

Cetrorelix is classified as "Исследования (прочее)", while Enfuvirtid is classified as "Исследования (прочее)". Cetrorelix: Cetrorelix is a synthetic decapeptide and GnRH antagonist. It is used in assisted reproduction (IVF) to prevent a premature LH surge during controlled ovarian stimulation. Enfuvirtid: Enfuvirtide is a synthetic 36-amino-acid peptide and the first HIV-1 fusion inhibitor. It binds the HR1 region of the viral envelope protein gp41, blocking viral entry into the cell. Approved for treatment-experienced HIV patients. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Cetrorelix or Enfuvirtid?

The highest available evidence level is "РКИ на людях" for Cetrorelix and "РКИ на людях" for Enfuvirtid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Cetrorelix and Enfuvirtid in Germany and the United States?

Германия: Cetrorelix — Рецептурный, Enfuvirtid — Рецептурный. США: Cetrorelix — Рецептурный, Enfuvirtid — Рецептурный. These are factual summaries with source and review date on the individual pages.